PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

Published:2016-07 Issue:8 Volume:5 Page:e1202391
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Munir Ahmad Shamaila,Martinenaite Evelina,Hansen Morten,Junker Niels,Borch Troels Holz,Met Özcan,Donia Marco,Svane Inge Marie,Andersen Mads Hald

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1202391

Reference25 articles.

1. Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells

2. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

3. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells

4. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta12,14-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway

5. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer;Translational Oncology;2024-04

2. Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy;Journal for ImmunoTherapy of Cancer;2023-03

3. Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives;Biomedicine & Pharmacotherapy;2023-03

4. An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial;Frontiers in Immunology;2023-02-23

5. Tumor microenvironment antigens;Seminars in Immunopathology;2022-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3